Generation of Neurotoxins by New Reaction Pathways of Dopamine under Oxidative Stress Conditions: Contributing Etiopathological Factors in Parkinson’s Disease

  • Alessandro Pezzella
  • Giuseppe Prota

Abstract

A marked alteration of cellular redox equilibria is commonly recognized as a critical condition associated to Parkinson’s disease and related neurodegenerative disorders (Jenner et al., 1992). Whatever the primary cause of injury resulting in the selective loss or dysfunction of nigrostriatal dopamine neurons, the persisting condition of oxidative stress has been suggested as a major pathogenic factor (Fahn and Cohen, 1992). According to this vision an intricate cascade of intra- and extraneuronal events involving, inter alia, an alteration of GSH and ascorbate levels (Perry et al., 1982), a marked increase in lipid peroxidation and malondialdehyde levels and, most important, an accelerated cytosolic dopamine deamination by MAO (monoamine oxidase) (Cohen, 1986), coupled with iron accumulation should result in the generation of highly cytotoxic hydroxyl radical and superoxide anion by Fenton and Haber-Weiss type reactions, capable of triggering lipid peroxidation leading to membrane damage and eventually to neuronal death (Adam et al., 1991) as well as to the formation of dopamine-derived cytotoxic species such as 6-hydroxydopamine.

Keywords

Dopamine DMSO Noradrenaline Neurol Epinephrine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adam, J.D. Jr., and Odunze, I.N., 1991, Oxygen free radicals and Parkinson’s disease, Free Rad. Biol. Med. 10: 161.CrossRefGoogle Scholar
  2. Cohen, G., 1986, Monoamine Oxidase and Parkinson’s disease, in: Advances in Neurology, Yahr, M.D., Bergmann, K.J., eds., Raven Press, New York, p. 119.Google Scholar
  3. Fahn, S., Cohen, G., 1992, The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it, Ann. Neurol. 32: 804.PubMedCrossRefGoogle Scholar
  4. Jenner, P., 1992, Oxidative stress as a cause of nigral cell death in Parkinson’s disease and incidental Lewy body diesase. The Royal Kings and Queens Parkinson’s Disease Research Group, Ann. Neurol. 32: S82.PubMedCrossRefGoogle Scholar
  5. Napolitano, A., Crescenzi, O., Pezzella, A., and Prota, G., 1995, Generation of the neurotoxin 6-hydroxydopamine by peroxidase/H2O2 oxidation of dopamine, J. Med. Chem. 38: 917.PubMedCrossRefGoogle Scholar
  6. Napolitano, A., Pezzella, A., and Prota, G., 1999, Tetrahedron Lett. 40: 2833.CrossRefGoogle Scholar
  7. Nishimura, M., Umeda, M., Kusanagi, A., Urakabe, R., Yukimatsu, K., and Otawara, S., 1981, Cytomorphological study of cultured mammalian cells treated with benzaldehyde, catechol and their derivatives with special reference to inhibition of DANN synthesis, Gann 72: 272.PubMedGoogle Scholar
  8. Perry, T.L., Godin, D.A., and Hansen, S., 1982, Parkinsons disease: a disorder due to nigral glutathion deficiency?, Neurosci. Lett. 33: 305.PubMedCrossRefGoogle Scholar
  9. Pezzella, A., d’Ischia, M., Napolitano, A., Misuraca, G., and Prota, G., 1997, Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinsons disease, J. Med. Chem. 42: 2211.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Alessandro Pezzella
    • 1
  • Giuseppe Prota
    • 1
  1. 1.Department of Organic and Biological ChemistryUniversity of Naples Federico IINaplesItaly

Personalised recommendations